|MMWR Weekly |
Volume 62, No. 45
November 15, 2013
PDF of this issue
Errata: Vol. 62, No. RR-9
WeeklyNovember 15, 2013 / 62(45);906
In the Recommendations and Reports, "Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis," three errors occurred.
On page 5, in Figure 1, the y-axis label should read, "Percentage of patients remaining sputum culture-positive."
On page 7, in Figure 2, the third footnote should read, "Time from baseline QTcF in weeks."
On page 8, under the heading "Deaths Among Clinical Trial Participants," the first sentence of the paragraph should read, "A total of 36 deaths were reported during the entire clinical development program of bedaquiline: 30 in the bedaquiline group and six in the placebo group (Table 5)."